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INTRODUCTION 
 
                                              World Health Organisation defines the clinical 
syndrome of “stroke” as ‘rapidly developing clinical signs of focal (or global) 
disturbance of cerebral function with symptoms lasting 24 hours or longer or 
leading to death, with no apparent cause other than vascular origin’.  After 
coronary heart disease (CHD) and cancer of all types, stroke is the third 
commonest cause of death worldwide. According to Stephen Macmahon et al, 
Worldwide, about 20 million people suffer from stroke each year; 5 million will 
die as a consequence and 15 million will survive; of those who survive, 5 million 
will be disabled by their stroke. A disease of such impact on human mortality and 
morbidity, stroke continues to take a heavy toll on the productivity of the 
population and the health care systems.   
                              Time and again it has been proved than stroke is the eventual 
result of a series of insults on the cerebral and cardiovascular systems. These risk 
factors not only determine when a stroke will occur, but also the type and severity 
of the cerebrovascular accident. The risk factors which lead on to stroke differs 
among different communities, changes with age, sex and many number of reasons. 
It implies that proper elucidation of the risk factors of stroke and the knowledge of 
the contribution each risk factor provides to the ultimate culmination in stroke can 
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help us devise preventive strategies. Since most of the studies are done in 
populations from developed nations, it is imperative that we need more studies 
from developing nations like India to find out corresponding statistics. 
Even among Indians there are considerable life style differences among 
populations from various communities and regions. So to be more specific we need 
studies from south India itself if we have to affirmatively assess the stroke indices 
in our population. 
                       The etiology of stroke in majority of cases could be identified by a 
proper history taking, an adequate general examination and judicious use of 
investigations. A cardiovascular examination and Imaging of the brain usually 
gives ample information regarding the etiology, type, site and severity of the 
stroke. Many studies conducted before show that ischemic strokes are common 
than hemorrhagic and the etiology is different for both. The etiology and site of 
stroke varies with different communities too. Statistic data on the etiology and site 
of strokes with proper correlation with brain imagery is still scanty for south Indian 
population. By this study an attempt is made to find out these indices with respect 
to a population catered by a tertiary care health system in Urban Tamil nadu.  
                    The clinical features that are common to stroke also varies with type 
of stroke. For example a history of loss of consciousness and seizures is more in 
favor of a hemorrhagic lesion. In addition lesions in various sites give rise to 
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different clinical pictures. An attempt is made to find out the clinical profile of 
stroke in this study population. The ultimate prognosis of the study population also 
will be seen. These data will help us to see how they differ from the western data. 
Thus they will let us set up our own guidelines for stroke management. 
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AIMS OF THE STUDY 
 
 
¾ To find out the various types and sites of stroke in patients 
admitted in Stanley medical college. 
¾ Find out the clinical profile of stroke in the study population. 
¾ Find out the most common etiologies of strokes in the study group. 
¾ To ascertain the frequency of various established risk factors for 
stroke. 
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METHODOLOGY 
 
Exclusion criteria: 
*Neurological deficits secondary to epilepsy  
* Head injury  
* Infective etiology 
* Metastatic etiology 
* Pre-existing severe physical or cognitive disability. 
Inclusion criteria: 
            Consecutive 100 cases which presented to Stanley Medical College with 
H/o and examination findings consistent with stroke. 
Study period: September 2007 to September 2008 
Study Tool:   
         This is an observational study conducted in a tertiary care set up. Patients 
fully evaluated and worked up in Stanley medical college, Chennai. 
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                           After taking a verbal consent from the patients/relatives, a detailed 
history is taken and a thorough physical examination (including cardiovascular and 
neurological) are performed according to a self-designed stroke questionnaire. The 
questionnaire documents the patient’s name, age, sex, past history of transient 
ischemic attack, valvular heart disease, smoking, alcoholism and family history 
etc. The findings of the clinical exam are also recorded in this predesigned form 
which includes the neurological status and associated cardiovascular abnormalities. 
Carotid bruits, valvular murmurs, Pulse and Blood pressure abnormalities are all 
noted. 
                                       The clinical presentation is observed and it includes 
general symptoms like loss of consciousness, vomiting, seizures etc and specific 
ones like hemiplegia, facio brachial monoplegia, cranial nerve palsies, Dysarthria, 
dysphagia, dysphasias etc. They are classified according to the sex of the patient 
and the type of stroke subsequently.  
                      The patients are subjected to radiological confirmation by CT scan 
(all patients) and in selected cases MRI scans and cerebral angiograms as 
necessary. In hemorrhage cases when needed MR angiograms were taken and 
suspected cortical venous thrombosis cases were subjected to MR venograms.  
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            The type of stroke, site, extend of lesion, associated anomalies are all 
noted. Patients are given treatment as needed along with neurology consultations. 
These patients are subjected to full Quota of blood tests including Complete blood 
count, renal function tests, liver function tests, Lipid Profiles, Fasting and Post 
prandial sugar, urinalysis, Chest X rays, ECGs and Echocardiogram in all cases. 
Coagulation profile was done to rule out coagulopathies in suspected cases.  
         These patients are further examined daily for 1 week. Their prognosis is 
noted by the clinical recovery status and by using the Glasgow Coma Scale.  
          The data is analyzed and sorted to see the types of stroke, and the differences 
between both sexes. The site is localized clinically and confirmed with CT scan. 
The various clinical manifestations throughout the hundred cases are categorised. 
The various risk factors are plotted down partly from history and partly from 
examination and investigations. History reveals smoking, alcoholism, past 
rheumatic heart disease, etc. Examination might reveal a carotid bruit or a cardiac 
murmur. Investigations are done for lipid abnormalities, diabetes and cardiac 
disorders. 
             The stoke types- ischemic and hemorrhagic are classified according to sex. 
Then the site of the lesion is found out with CT scan and strokes are classified 
according to the Oxfordshire Classification Scale7 as Total Anterior circulatory 
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stroke, Partial Anterior circulatory stroke, Lacunar strokes and Posterior circulation 
strokes. The aetiology is then laid out according to the TOAST classification into 
Large artery atherosclerosis, Cardioembolism, Lacunar (small vessel disease), 
other (rare causes, e.g. Vasculitis, Dissection, Fibromuscular dysplasia, Migraine, 
Venous infarction, other) and Undetermined. In patients with hemorrhage 
coagulation workup and Platelet counts are done to rule out thrombocytopenic 
conditions (like leukemias) and hemophilic conditions.    
             In summary, this thesis is an observational study conducted on patients 
with clinical features of stroke, confirmed by brain imaging. The study group will 
be worked up for the etiological diagnosis with full cardiovascular evaluation and 
follow up for 1 week. The risk factors leading to the stroke and the resultant type, 
site and prognosis of stroke are studied. This study would thus shed light on the 
clinico-radiological profile and risk factors underlying stroke in south Indian 
population.   
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Definition of Stroke 
Stroke is defined as “focal (or at times global) neurological impairment of sudden onset, 
and lasting more than 24 hours (or leading to death) with no apparent cause other than 
vascular origin” –WHO1 
The 24-hour time limit for the duration of symptoms was defined by a WHO committee 
in 1978 on purely arbitrary grounds.  
The definition includes stroke due to: 
¾ Ischaemic stroke or cerebral infarction: inadequate blood supply to a part of the 
brain as a result of low blood flow, thrombosis or embolism associated with 
diseases of the blood vessels, heart or blood. 
¾ Haemorrhagic stroke: spontaneous haemorrhage into or over the brain substance, 
primary intracerebral haemorrhage or subarachnoid haemorrhage respectively. 
The definition does not include stroke caused by trauma, infection or tumour that lead to 
subarachnoid haemorrhage, subdural haemorrhage, epidural haemorrhage, intracerebral 
haemorrhage or infarction. The definition also excludes subarachnoid haemorrhage with 
headache, but without a focal or global neurological dysfunction (Hankey & Lees 2001). 
Transient ischaemic attack (TIA) which shares common risk factors and pathophysiology 
to stroke, but is of short duration (defined as symptoms lasting less than 24 hrs) and its 
outcome does not lead to any disability, as the stroke.  
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Stroke Syndromes by anatomy8 
Cortical strokes 
Middle cerebral artery ¾ Contralateral hemiparesis and sensory loss face 
and upper extremity more involved. 
¾ Contralateral hemianopia 
¾ aphasia/aprosodia 
¾ gaze abnormalities 
¾ extinction on simultaneous touching, apraxia 
 
Anterior cerebral artery ¾ contralateral hemiparesis and sensory loss, lower 
extremity more involved 
¾ disconnection syndrome 
¾ abulia, akinetic mutism 
Posterior cerebral artery ¾ contralateral hemianopia with macular sparing 
¾ disconnection syndrome 
Lacunar syndromes of cerebral hemisphere (no diplopia) 
Ventral posterior thalamus ¾ pure sensory loss without weakness 
Post limb Internal Capsule ¾ pure motor weakness without sensory loss, 
confusion or visual field defect 
Genu of internal capsule ¾ Dysarthria clumsy hand syndrome 
Subthalamic nucleus ¾ Contralateral Hemiballismus 
Midbrain syndromes ( III nerve palsy or vertical gaze problem) 
Tegmentum, red nucleus, III n ¾ Claude's syndrome: Ipsilateral III palsy &  
contralateral ataxia 
above plus cerebral peduncle ¾ Benedikt's syndrome: above plus contralateral 
weakness 
III nerve + cerebral peduncle (red 
nucleus spared) 
¾ Weber's syndrome: ipsilateral III palsy + 
contralateral weakness 
Dorsal midbrain ¾ Perinaud's syndrome: paralysis of up gaze, 
convergence- retraction nystagmus, lid retraction 
Above + paramedian  midbrain ¾ Nothnagel's syndrome: III palsy, vertical gaze 
paralysis, ipsilateral ataxia 
Pontine syndromes ( VI nerve, horizontal gaze problem or VII nerve palsy) 
Middle cerebellar peduncle + 
corticospinal tract 
Raymond-Cestan syndrome: ipsilateral ataxia + 
contralateral weakness 
Paramedian pons One-and-a-half syndrome: ipsilateral horizontal gaze 
palsy plus contralateral INO 
Ventral pons Millard-Gubler syndrome: VI & VII palsy, contralateral 
hemiparesis 
Medulla syndromes (facial sensory loss\ Horner's syndrome, ipsilateral tongue, palate) 
Dorsolateral medulla Wallenberg's syndrome: ipsilateral ataxia, Horner's 
syndrome, facial sensory loss, contralateral loss of pain 
& temperature 
Lateral medulla Ipsilateral ataxia, horner's syndrome, facial sensory loss, 
ipsilateral paralysis of soft palate, vocal cords or 
sternocleidomastoid 
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Clinical Classification and Aetiological 
Categorization of Stroke: 
The common clinical stroke syndromes are defined using the Oxfordshire 
classification (Bamford et al. 1991)7:  
¾ Total anterior circulation syndrome (TACS) – approximately 20% of cases 
¾ Partial anterior circulation syndrome (PACS) – approximately 30% of cases 
¾ Lacunar Syndrome (LACS) – approximately 25% of cases 
¾ Posterior circulation syndrome (POCS) – approximately 25% of cases 
These syndromes are based on the clinical features (Table 1). However, they can 
be further refined by CT or MRI brain scan findings. Classification of the stroke 
syndromes is important as it provides valuable information about the anatomical 
and vascular location, aetiology and prognosis of the stroke (Table 2) (Hankey & 
Lees 2001).  
Ischaemic stroke can be further divided into various subtypes, as defined by the 
TOAST study, the Trial of Org 10172 in Acute Stroke Treatment (Adams et al. 
1993) (Table 3). This subtype classification is closely associated with the 
underlying pathophysiology of ischaemic stroke and can be used in targeting 
treatment. 
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Table 1: Stroke Syndrome Using Oxfordshire Classification Scale7 
Classification   
Total Anterior Circulation syndrome 
(TACS) 
 
 
 
 
Partial Anterior Circulation Syndrome 
(PACS) 
 
 
Lacunar Syndrome 
(LACS) 
 
 
 
 
Posterior Circulation Syndrome 
(POCS) 
 
 
 
 
Syndrome 
Combination of: 
¾ Hemiparesis+/-hemisensory loss 
¾ Homonymous hemianopia 
¾ Global aphasia (dominant 
hemisphere) or  visuo-spatial                              
deficit/neglect (non-dominant                              
hemisphere)  with or without 
drowsiness 
 
 Two of the three components of TACI 
Dysphasia typically related to either 
expressive or receptive. Typically no 
drowsiness 
 
¾ Pure motor stroke, or 
¾ Sensory-motor stroke, or 
¾ Pure sensory stroke, or 
¾ Ataxic hemiparesis, or 
¾ Dysarthria clumsy-hand 
syndrome 
No hemianopia or cortical dysfunction   
 
Ipsilateral cranial nerve palsy with 
contralateral motor and/or sensory 
deficit/neglect 
Conjugate gaze disorder 
Cerebellar dysfunction without ipsilateral 
long tract signs 
Isolated homonymous hemianopia
Source: Adapted from Hankey 2001 (Hankey & Lees 2001). 
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Table 2: Anatomy, Pathology, Aetiology and Prognosis of the Four Clinical 
Stroke Syndromes 
 TACS PACS LACS POCS 
Anatomy Fronto-
temporalparietal 
lobes or 
thalamus/internal
capsule/occipital 
Lobar Small deep 
lesion in corona 
radiata, internal 
capsule, 
thalamus or 
ventral pons 
 
Pathology, (%)  
Infarction  85 85 95-98 85 
Hemorrhage 15 15 2-5 15 
Aetiology  
Infarction Occlusion of 
ipsilateral ICA 
or MCA, and 
occasionally 
PCA; by 
embolism from 
heart, aortic arch 
or carotid or 
vertebrobasillar 
arteries, or insitu 
thrombosis 
Occlusion of 
branch of 
MCA or 
PCA; by 
embolism 
from heart, 
aortic 
Usually 
lipohyalinosis, 
microatheroma 
or ‘complex’ 
disease 
(fibrinoid 
necrosis) of 
small 
perforating 
artery. Rarely 
arteritis or 
embolism 
Occlusion of 
VBA or PCA, 
or branches; 
by in-situ 
thrombosis or 
embolism 
from heart, 
aortic arch or 
VBA 
Haemorrhage Any of possible 
causes 
Any of possible
causes 
Any of possible 
causes 
Any of possible 
causes 
Recurrence 
rates 
Low High in first 3 
months 
Low but steady 
over 12 months 
High first 2 
months and 
steady over 12 
months 
 
TACS, Total Anterior Circulation Syndrome; PACS, Partial Anterior Circulation 
Syndrome; LACS, Lacunar Syndrome; POCS, Posterior Circulation Syndrome; ICA, 
internal carotid artery; MCA, middle cerebral artery; PCA, posterior cerebral artery; 
VBA, vertebral-basilar artery. 
Source: adapted from Hankey 2001 (Hankey & Lees 2001). 
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Table 3: TOAST Classification of Aetiology of Ischaemic Stroke 
 
    Aetiology of Ischemic Stroke 
1. Large artery atherosclerosis 
2. Cardioembolism 
3. Lacunar (small vessel disease) 
4. Other (rare causes, e.g. Vasculitis, Dissection, Fibromuscular dysplasia, 
Migraine, Venous infarction, other) 
5. Undetermined 
 
TOAST, Trial of Org 10172 in Acute Stroke Treatment 
Source: Modified from Adams (Adams et al. 1993). 
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Epidemiology of Stroke 
Mortality 
                According to the World Health Organisation (WHO), stroke is the second 
worldwide leading cause of mortality. In addition a large proportion of the 
population is debilitated and rendered functionally dependent. Worldwide, about 
20 million people suffer from stroke each year; 5.5 million will die as a 
consequence and 14.5 million will survive; of those, who survive, 5 million will be 
disabled by their stroke. Of those deaths, two thirds occur among people living in 
developing countries. So, the global burden of stroke needs to be defined for 
developed and developing nations. 
Morbidity 
           In terms of disability, stroke is among the five most important causes of 
disability in both developing and developed countries (World Health 
Organisation). It will lead on to long term disability and a burden on health care 
facilities. 
        The Global Burden of Disease (GBD)3 Study, in 1990, reported 9.4 million 
deaths in India of which 61,900 were from “Stroke” and the disability adjusted life 
years (DALYs) lost almost amounted to 28.5 million - nearly six times higher than 
that due to malaria. When these estimates were projected for the year 2020, Murrey 
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and Lopez4 reported that 61 million DALYs are likely to be lost due to stroke, of 
these 52 million (84%) will be in the developing countries. Reddy and Yusuf9 have 
reemphasized the “Health Care and Economic Consequences” of emerging 
epidemic of cardiovascular diseases in developing countries.  
 
Incidence and Prevalence 
         The incidence and prevalence of stroke varies in different communities and 
countries. For example, it is estimated that approximately 4.5 million Americans 
are currently living with the effects of stroke, and that every year another 570,000 
will survive a stroke that results in disability. Stroke is the third most common 
cause of death in the United States.2 According to WHO the age-standardised 
incidence rates per 100,000 varied from 101 to 285 in men and from 47 to 198 in 
women. (Thorvaldsen et al. 1995)6  
        Brain stroke is the third largest killer in India after heart attack and cancer and 
the second largest in the world, according to the World Health Organisation 
(WHO). India will face an enormous socio-economic burden to meet the costs of 
rehabilitation of “stroke victims” because the population comprising the peak years 
(age 55-65) of occurrence of stroke is gradually increasing. However, for stroke 
prevention planning, reliable epidemiological information on pattern of disease and 
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exposure to risk factors and morbidity or mortality trends for CVD in defined 
populations is not available. Recent community surveys15 for “hemiplegia” 
presumed to be CVD, identified 320 cases in 145,456 persons, indicating an 
overall Crude Prevalence Rate (CPR) of 220 per 100,000 persons.  
        During the last decade, the age-adjusted prevalence rate of stroke was 
between 250-350/100,000. Recent studies showed that the age-adjusted annual 
incidence rate was 105/100,000 in the urban community of Kolkata and 
262/100,000 in a rural community of Bengal. The ratio of cerebral infarct to 
hemorrhage was 2.21. Hypertension was the most important risk factor. Stroke 
represented 1.2% of total deaths in India. 
        Many studies have shown that the incidence and mortality of stroke has 
declined in the past 20 years, particularly in many developed countries (Sudlow & 
Warlow11 1996; Rothwell et al. 2004)12. Two prospective stroke studies,14 during 
the period 1963-1968 and 1978-1982 in Bombay, using identical methodologies, it 
was observed that there was a significant drop in case fatality rate (32% to 12%) 
thereby resulting in a higher survival (68% to 88%) but with residual disability. 
Thus, these changing trends have posed a major social challenge in occupational 
rehabilitation and in solving the needs for stroke survivors. These data suggest that 
India is already facing “Stroke Epidemic”. 
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Regional and Community wise variations 
             Incidence and risk factors of stroke vary among different communities and 
regional groups. For example, in the US, the incidence of cerebrovascular disease 
is higher in African Americans and some Hispanic Americans (Howard et al. 1994; 
Gorelick 1998)10. Understanding the ethnic variations of stroke epidemiology may 
be of value in defining stroke prevention and management strategies; especially in 
multiethnic populations. The incidence of stroke is heterogeneous among 
populations and changes over time. A large number of studies have been conducted 
to examine stroke incidence and prevalence as well as stroke types across different 
regions and countries.  
                   In Indian subcontinent with the multitude of regional and cultural 
variations, studies need to be conducted in every subset to identify the distribution 
and risk factors of stroke. This will enable us in targeting effective therapy in a 
customized manner. For example, a recent survey on 20,842 rural residents in East 
India13 reported a crude prevalence rate for stroke in elderly (age 41-60 yrs) at 
540/100,000, which differs in statistics from the rest of the country. This thesis 
intends throw light into this situation regarding the South Indian scenario. 
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Comparison of Stroke Type in various regions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reference Country Sample 
size 
Ischaemic 
stroke 
(%) 
Haemorrhagic 
stroke (%) 
SAH 
(%) 
Unknown 
(%) 
(Sze et al. 
2000) 
HK, China 793 84 16 -- -- 
(Giroud et 
al. 1989) 
Dijon, France 203 80 15 5 5 
(Saposnik & 
Del Brutto 
2003) 
South America -- 51-73 26 - 46 -- -- 
(Saposnik et 
al. 2000) 
Argentina, South 
America 
361 73 27 -- -- 
Whites 995 81 13 6 -- (Hajat et al. 
2001) 
South 
London,UK 
Blacks 230 69 19 12  
(Johansson 
et al. 2000) 
Sweden 1318 74 11.5 4.5 10 
(Bamford et 
al. 1988) 
Oxfordshire, UK 675 81 10 5 5 
(Lefkovits et 
al. 1992) 
Melbourne, 
Australia 
925 75 16 9 o 
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Stroke Risk Factors and Risk Factor Management 
 
Overview of Stroke Risk Factors 
 
                 Although stroke mortality is declining in the west, identifying the clinical 
patterns and the risk factors and intervening to control or modify them remain the 
most important means of reducing stroke incidence16. Most of the local, South 
Asian and the far eastern studies have suggested that the proportion of intracerebral 
hemorrhage was significantly higher 21% to 45% than in the west 10% to 20% 
while cerebral infarction varied between 55% to 70.1% in the local studies and 
60% to 84% in the western.16, 17, 18 Although some determinants of stroke, such as 
age, gender, race, ethnicity and heredity cannot be modified, they are risk markers. 
                   Identification and management of stroke risk factors is an important 
strategy for both primary and secondary stroke prevention. Risk factors for stroke 
have been classified as non-modifiable, partially modifiable and modifiable 
(Goldstein et al.2001). There are also potential risk factors that have been 
described in a number of recent publications (Sacco 2001).  
The significance of a risk factor for an individual is determined by the relative risk 
RR), which represents the strength of the association between the risk factor and 
the chance of having a stroke (Hennekens & Buring 1987). On the other hand, the 
population attributable risk (PAR) is more relevant to the importance of a risk 
factor in a population (Hennekens & Buring 1987). For example, although the 
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relative risk of hypertension for stroke is not high, the fact that the prevalence of 
hypertension in the population is high means that there is a high population-
attributable risk of hypertension. Therefore, treatment of hypertension in the 
general population has a higher impact on the prevention of stroke than that of a 
risk factor with a lower prevalence but higher relative risk, e.g. atrial fibrillation. 
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Summary of Risk Factors for Ischaemic Stroke19 
 
 
Ischaemic stroke Relative 
risk 
Estimated 
Age standardized 
prevalence of 
exposure in 
population 
(%) 
Population 
attributable 
Risk (%) 
Non-modifiable  
Age  -- -- -- 
Gender -- -- -- 
Heredity(race, 
ethnicity, family 
history) 
-- -- -- 
Modifiable – well documented 
Hypertension 2-4 30 15-22.5 
Diabetes Mellitus 2 20-25 12.5 
Atrial Fibrillation 6 1 0.8 
Lipid disorder 
(hypercholesterolemia) 
1.8-2.6 51 25 
Cigarette smoking 2-4 25 12.5 – 18.8 
Peripheral vascular 
disease 
1-4 3 0 – 2.25 
TIA or previous stroke 7 2 1.7 
Ischaemic heart 
disease (IHD) 
1-3 20 0 – 13.3 
Carotid bruit/stenosis 3-15 4 0.4 – 0.9 
Modifiable – less well-documented 
Obesity -- 60 -- 
Heavy alcohol drinking -- 10 -- 
Illicit drug use -- -- -- 
Physical inactivity -- 54 -- 
Poor nutrition -- -- -- 
Oral contraceptives -- -- -- 
Migraine -- -- -- 
Hemostatic and 
inflammatory 
factors 
-- -- -- 
Homocysteine -- -- -- 
C-creative protein  -- -- -- 
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Summary of Risk Factors for Haemorrhagic Stroke20 
 
 
Major risk factors  
 
Hypertensive small vessel disease (fibrinoid necrosis) 
Vascular malformations 
Intracerebral tumours 
Septic arteritis and mycotic aneurysms 
Hypertension, isolated systolic blood pressure 
Left ventricular hypertrophy 
Prior stroke 
Amyloid angiopathy 
Anticoagulation, thrombolytic therapy 
Clotting factor deficiency 
Leukaemia and thrombocytopenia 
 
Minor risk factors 
 
Heavy alcohol use 
Cocaine and other sympathomimetic drugs 
Age 
Socioeconomic status 
Very low serum cholesterol 
Cigarette smoking 
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Non-Modifiable Risk Factors 
                 Age, gender, family history, race and ethnicity are non-modifiable risk 
factors for stroke (Goldstein et al. 2001)21. These factors denote the population 
group that will be at a high risk for stroke, but cannot be targeted by preventive 
measures. 
 Age 
                 In adults, stroke risk more than doubles in each decade over age 55 
years (Wolf et al. 1992). The mean age of stroke presentation 57 to 71 years is 
relatively lesser in Asian population than in the west 76 to 80 years.19, 22, 23. 
Increasing age is clearly the strongest determinant of the number of new cases of 
stroke each year. (Simons et al. 1998)24; 97% of ischaemic stroke occur among 
people over the age of 45 (Adams et al. 1992)25. About 75% of strokes occur in 
people 65 years and older and approximately 50% occur in people aged greater 
than 75 years (Bamford et al. 1990)7. The cause of stroke also varies by age. In the 
elderly, atherosclerosis and cardio embolism secondary to atrial fibrillation are the 
leading causes of ischaemic stroke (Atrial Fibrillation Investigators 1994), while 
cerebral amyloid angiopathy and chronic hypertension are leading causes of 
intracerebral haemorrhage in the elderly ( Rasool et al. 2004)26. 
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Family History 
          Persons with a family history of stroke are put to an increased risk for 
sustaining a stroke. It may be due to sharing of common cultural patterns and 
lifestyle or due to inherited coagulopathies or tendencies for intracranial aneurysms 
and AV malformations. The risk of stroke increases by 40 and 140% respectively 
with a maternal or parental history of stroke or TIA.27 
Gender 
          Stroke risk factors, type and aetiology differ between men and women. Men 
are at a greater risk for stroke than women. Women tend to live longer than men 
who die of other co morbidities; as a result, they often outnumber men in stroke 
prevalence figures.19 
           Age-specific incidence rate of stroke for men within the 45 to 84 yr age 
group is observed to be 174/100,000 against 122/100,000 in females.19. This 30% 
higher incidence of stroke in men has been observed in many studies. (Bamford et 
al. 1988)7. Gender has a role in the cause of stroke also. Strokes due to pregnancy, 
puerperium, oral contraceptive use, migraine or saccular aneurysms are more 
common in women, while atherosclerosis is more common in men (Adams et al. 
2002).25 
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Incidence of Stroke in Male and Female versus Age, Results from 
Oxfordshire7 Study 
 
 
 
 
Race and Ethnicity 
 After coronary heart disease (CHD) and cancer of all types, stroke is the third 
commonest cause of death worldwide. Compared to Caucasians, Asians have a 
lower rate of CHD and a higher prevalence of stroke28.  Among the Asians, the 
number who died from stroke was more than three times that for CHD.29,30  In one 
report, the age standardized, gender-specific stroke mortality rate was 44 to 
102.6/100,000 for Asian males, compared with only 19.3 for Australian white 
males.31 In the early 1980s the prevalence rates of stroke were around 500-700 per 
100,000 in the western countries and 900 per 100,000 in Asia.32 The disparity 
between the stroke and CHD incidence is usually attributed to high prevalence of 
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hypertension and low levels of blood lipids among Asians.33 Hypertension was 
related to high salt intake and perhaps to genetic factors and low serum lipid was 
due to low levels of animal fats and protein in oriental diet. Among Asians stroke 
has been found to be more common among the Chinese and Japanese. The 
incidence of stroke for African American is more than double that of Caucasians 
(233/100,000 versus 93/100,000)19, 34 Again it appears to be influenced by the 
prevalence of certain risk factors in that particular race. The African Americans 
have a high prevalence of hypertension, sickle cell disease, poor diet and lower 
economic and social factors than Caucasians.21 
 
Modifiable Risk Factors 
According to the American Heart Association (AHA), modifiable risk factors are 
defined as “well documented”, “less well-documented” or “potential” risk factors 
(Goldstein et al. 2001). 21 The major risk factors are as follows. 
Hypertension 
       Hypertension is the single most powerful and important modifiable risk factor 
causing stroke. In hypertensives a fourfold greater risk of stroke at systolic blood 
pressure values ≥160 has been observed.19 Treatment of hypertension reduces 
stroke risk by approximately 38%. 21   Reduction of blood pressure is associated 
with a reduced incidence of stroke in elderly by 40% (Sacco et al. 1997)19. The 
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most prevalent form of hypertension among elderly is Isolated Systolic 
hypertension. The risk of stroke increases with systolic blood pressure in all age 
groups. However, the effects of blood pressure lowering agents may vary in 
different age groups (Prospective Studies Collaboration 1995).20  
Diabetes Mellitus 
        Diabetes mellitus is an important risk factor for stroke. It causes chronic end 
organ damage, accelerates atherosclerosis and leads on to stroke and heart disease. 
The risk of stroke in patients with diabetes mellitus is about 4 times that found in 
normal individuals.19 Poorly controlled diabetes mellitus is associated with long-
term damage, dysfunction and failure of various organs; including eyes, kidneys, 
nerves, heart and blood vessels (Meneilly & Tessier 2001).25 It is an important risk 
factor for heart disease and stroke.19, 36   The frequency of diabetes mellitus was 
found to be higher in Indian population 18%-42.5% 17 than in the western 10% to 
26%. 37 
Cigarette Smoking and tobacco chewing 
                                          Cigarette smoking is considered to be a major risk factor for 
stroke. The estimated relative risk for stroke among smokers is 1.5 to 2.9 times that 
of nonsmokers (Shinton & Beevers 1989).40 Many studies have confirmed the role 
of active cigarette smoking as a major risk factor for stroke.38, 39 Smoking leads on 
to increased atherosclerosis and vessel wall changes. Smoking causes reduced 
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blood vessel distensibility and compliance by leading to increased arterial wall 
stiffness. Smoking causes increased fibrinogen levels, increased platelet 
aggregation, decreased high-density lipoprotein (HDL) levels and increased 
haematocrit (Goldstein et al. 2001).21  
                                    The relative risk of ischaemic stroke in current smokers has 
been estimated as 1.9 However, cessation of smoking reduced the risk of stroke 
and returned the relative risk to the baseline level after 5 years of cessation 
(Goldstein et al. 2001)21, which makes it an important intervention in the 
prevention of stroke. After 5–10 years, people who quit smoking reduce their risk 
of stroke to that of nonsmokers.19  
                              Many local studies have shown somewhat similar pattern of 
smoking/tobacco chewing as those in the west.37, 41, 19, 22, 23  Betel nut chewing with 
or without tobacco is associated with increased risk of stroke according to some 
studies.45 Areca nut chewing will lead on to increased periodontal disease which in 
turn can lead on to increased stroke.43, 44 For example, the results of a meta-analysis 
of nine cohort studies indicate that the relative risks of future cardiovascular events 
and stroke for persons with periodontal disease were 1.44 and 2.85, respectively. 42 
Further studies are needed to confirm and to find out the reasons why 
cerebrovascular mortality is increased in tobacco chewing. 
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Alcohol Drinking 
          The protective effect of moderate alcohol drinking has been demonstrated in 
a number of epidemiological studies. 19, 46In the Melbourne Risk Factor Study long 
term heavy alcohol consumption was identified as a major risk factor.  Heavy 
alcohol consumption has been associated with an increased incidence of 
haemorrhagic stroke (Thrift et al. 1999)46. According to another study drinking 
habits were associated only with deaths from ischemic stroke, and the risk patterns 
were different for men and women.47 Heavy drinking may be considered when 
males take more than 3 drinks (33-45g) and females take more than 2 drinks (22-
30g) per day. 
Atrial Fibrillation  
         Atrial fibrillation is an important risk factor for stroke. In the Copenhagen 
stroke study it was shown that Stroke in patients with AF is generally more severe 
and outcome markedly poorer than in patients with sinus rhythm. This accentuates 
the importance of anticoagulant treatment of individuals with AF48 Its prevalence 
begins to increase in both genders after age 40 years and rises rapidly after age 65 
years. AF increased steeply with age in the stroke population, from 2% in patients 
<50 years old, 15% in patients in their 70s, and 28% in patients in their 80s, to 
40% in patients ≥90 years of age.48 It is also an important attributing factor for 
stroke outcomes (Marini et al. 2005).49 AF is a common cause and independent 
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risk factor for cardio-embolic stroke. It is associated with about 16% of all 
ischaemic stroke (Wolf et al. 1991a).50 Studies like the Stroke Prevention in Atrial 
Fibrillation (SPAF) III trial showed that anticoagulation therapy using warfarin is 
superior to aspirin in the prevention of cardio-embolic strokes in individuals with 
high risk of stroke (Hart et al. 2003). AF is a predictive factor for severe stroke and 
early death in acute ischaemic stroke.53 
Lipid Disorder 
                          Lipid profiles, including total blood cholesterol, High Density 
Lipoprotein (HDL), Low Density Lipoprotein (LDL) and triglyceride levels have 
been used as indicators for the risk of stroke. Increased level of total cholesterol, 
especially LDL, is associated with a higher incidence of ischaemic stroke.51 But a 
low level of total cholesterol can be associated with an increased risk of 
haemorrhagic stroke.46, 51 Over the past few years it has been demonstrated that 
strong correlation between lipid lowering therapy and the incidence of stroke 
exists. A meta-analysis showed that statins reduced the incidence of fatal and non-
fatal stroke by 20-25% (Briel et al. 2004).52 
Hyperhomocysteinemia 
                       Homocysteinemia is a stroke risk factor.19 It predisposes young 
individuals for strokes and other vascular events due to the procoagulant state it 
creates. It is a sulphur-containing amino acid derived from catabolism of the 
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essential amino acid methionine. Abnormalities in the function of certain enzymes 
that metabolise methionine, or deficiencies in folic acid, vitamin B6, or vitamin 
B12 cofactors, can lead to elevated homocysteine levels – called 
Hyperhomocysteinemia. Endothelial injury and acceleration of atherosclerosis is 
noted in hyperhomocystinemia. The increased risk of stroke in 
Hyperhomocysteinemia is contributed by both genetic and environmental factors. 
A meta-analysis of 30 observational studies showed that a 25% lower usual 
homocysteine level was associated with a 19% lower stroke risk (Homocysteine 
Studies Collaboration 2002).   
Physical activity 
                        The Framingham study results indicate that medium and high levels 
of physical activity among men are protective against stroke relative to low 
levels.54 The protective effect of physical activity in the elderly was observed in the 
Northern Manhattan Stroke study. In women physical activity, including moderate-
intensity exercise such as walking, is associated with substantial reduction in risk 
of total and ischemic stroke in a dose-response manner.55 
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Stroke Prevention 
         Stroke once occurs can lead on to mortality and significant morbidity. Since 
our knowledge regarding the etiology and risk factors of stroke is increasing day 
by day, it is evident that strokes can be prevented. The various risk factors of 
stroke that can be modified should be targeted. It would be prudent to identify high 
risk groups and stroke survivors and provide stroke preventive therapy to them. 
Successful prevention eliminates the expenses of acute stroke treatment, 
rehabilitation and subsequent lost productivity and long-term care and disability 
cost (Hankey 1999). This involves treating conditions like diabetes, dyslipidemia 
and hypertension and also life style modification strategies like smoking and 
alcohol cessation, physical activity and dietary modifications.  
             Risk factor modification can be attempted either by targeting the general 
population or the high risk populations.19 Attempting to provide stroke prevention 
therapy to the general population is not cost effective. Whereas identifying and 
giving therapy to people with risk factors for stroke is cost effective and leads to a 
significant reduction in morbidity and mortality from stroke. There are primary and 
secondary preventive strategies for stroke. A patient with symptomatic 
cerebrovascular disease is likely to have other cardiovascular diseases or is 
predisposed to develop them. Preventive measures should complement reduction in 
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risk of atherothrombotic events in the coronary arteries and other arterial 
territories. 
Primary Prevention of Stroke 
                       Primary prevention is aimed at preventing an individual’s first ever 
stroke. This involves preventing the risk factors from emerging as well as treating 
them. So individuals with no risk factors like hyper tension and diabetes are 
advised regarding measures to prevent them from occurring. This includes 
smoking and alcohol cessation, taking on healthy diet and exercise patterns and so 
on. This involves the use of mass media and public education systems.19 Stroke 
prevention strategies deployed after development of well-established risk factors 
for stroke have developed are also having a significant reduction in stroke 
incidence. For example, lowering blood pressure and anticoagulant therapy for 
atrial fibrillation have reduced the incidence of stroke significantly (Atrial 
Fibrillation Investigators 1994; O'Brien et al. 1999; Donnan et al. 2003b). So by 
targeting such population a heavy economic benefit is obtained by reducing the 
number of strokes and the DALY s which would have been lost otherwise.  
Secondary Prevention of Stroke 
Secondary prevention is given to prevent recurrent stroke in stroke survivors. This 
also includes treatment of people who have evidence of atherosclerosis such as 
myocardial infarction, angina pectoris, claudication, amaurosis fugax and transient 
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ischaemic attack (Adams et al. 2002). The risk of recurrent stroke can still be 
reduced by risk factor modification (Organizing Committees 1998). In developing 
nations many of the time patients are picked up and risk factors identified only 
after they sustain a stroke. So, secondary prevention of stroke holds the key to 
reduce the morbidity and mortality in such high risk populations. 
 
Therapies for Prevention of Stroke 
Several interventions have been identified as lowering the incidence of stroke. 
They are enumerated below. 
Antihypertensives: 
               Treating and controlling hypertension is one of the most effective 
strategies to reduce the incidence of stroke. The successful management of 
hypertension is probably one of the leading reasons why stroke incidence has 
declined during the past 20 years. (Hall et al. 1991, the HOPE study). Several 
studies show that no demonstrable floor exists for the relation between blood 
pressure and risk of stroke, with risk continuing to halve for every 10 mm Hg fall 
in diastolic pressure even at conventionally normotensive values.57 Meta-analyses 
of small trials of antihypertensive treatment in patients with a stroke showed a 28% 
reduction in relative risk for stroke regardless of baseline blood pressure.56   This 
was supported by the post-stroke antihypertensive study (PATS),58 in which 
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indapamide gave an absolute reduction in stroke risk by 2.9% compared with 
placebo over three years  in 5665 patients with prior stroke or transient ischaemic 
attack and mean baseline blood pressure of 154/93 mm Hg. 
                      The rate of stroke in patients with hypertension is age dependent. 
Results from a pooled analysis from 45 prospective studies involving 450,000 
patients showed that the absolute stroke rates were 2, 5 and 8 per 1000 for age 
group <45, 45-65 and >65 respectively (Prospective Studies Collaboration 1995). 
The Heart Outcomes Prevention Evaluation (HOPE) study was a randomised, 
placebo-controlled trial in patients with a history of vascular disease, with 4645 
patients randomised to receive 10mg once a day of ramipril and 4652 patients to 
receive a placebo. Results showed that there was a reduction in stroke incidence in 
the intervention group (Relative Risk Reduction, RRR = 32%, Absolute Risk 
Reduction, ARR = 1.5%), In the Perindopril Protection Against Recurrent Stroke 
Study (PROGRESS), a combination of perindopril and indapamide significantly 
reduced the risk of recurrent stroke. 
Antithrombotic Therapy:  
Antithrombotic therapy includes antiplatelet (e.g. aspirin, clopidogrel, and 
dipyridamole) and anticoagulation (e.g. warfarin) therapy. 
                        In a meta-analysis of results of 21 randomized trials comparing 
antiplatelet therapy with placebo in 18 270 patients with prior stroke or TIA, 
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antiplatelet therapy was associated with a 28% relative odds reduction in nonfatal 
strokes and a 16% reduction in fatal strokes.61 Antiplatelet usage after transient 
ischaemic attack also has been shown to be effective in stroke prevention (Sacco & 
Elkind 2000; Antithrombotic Trialists' Collaboration 2002). 
                The effectiveness and safety of antiplatelet therapy for primary stroke 
prevention in patients with atrial fibrillation has been examined in many large-
scale trials. Many studies have established an irrefutable role for aspirin in 
preventing stroke. These studies include the Stroke Prevention in Atrial Fibrillation 
(SPAF I) study, the Atrial Fibrillation, Aspirin, Anticoagulation (AFASAK I) 
study and the Low-dose Aspirin, Stroke, Atrial Fibrillation (LASAF) study. A total 
of 1965 subjects were included in these three trials with a mean follow-up period 
of 1.3 years (equivalent to 2560 patient years). The results showed that aspirin was 
associated with a reduction of ischaemic stroke and all cause mortality.   
              The efficacy of clopidogrel was compared with that of aspirin in the 
Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) trial. 
It showed that efficacy of clopidogrel in the dose of 75 mg daily is comparable to 
Aspirin 325 mg daily. It was associated with lesser gastrointestinal symptoms. 
             The meta-analysis by Hart et al using adjusted dose warfarin with a total of 
2900 subjects, found that warfarin reduced stroke by 62% with an absolute risk 
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reduction of 2.7% per year for primary stroke prevention and 8.4% per year for 
secondary stroke prevention. The Stroke Prevention in Reversible Ischemia Trial 
(SPIRIT) was stopped early because of increased bleeding among those treated 
with high-intensity oral anticoagulation (INR, 3.0 to 4.5) compared with aspirin 
(30 mg/d) in 1316 patients. For patients with non cardioembolic ischemic stroke or 
TIA, antiplatelet agents rather than oral anticoagulation are recommended to 
reduce the risk of recurrent stroke and other cardiovascular events. But 
anticoagulant therapy is more potent than antiplatelet for stroke prevention in 
patients with atrial fibrillation. 
Preventing embolism: 
                           For patients with atrial fibrillation, dose-adjusted warfarin sodium 
is administered to keep the international normalized ratio [INR] in the 2 to 3 range; 
target 2.5) unless there is a specific contraindication for that medication.59 In the 
latter case, the patient should be treated with aspirin 50 to 325 mg/d. 
                        In patients with TIA or mild stroke and symptoms referable to 
severe (70% to 99%) carotid artery stenosis (or to moderate [50% to 69%] stenosis 
in a patient with significant risk factors), the treatment of choice is carotid 
endarterectomy by a surgeon with a low complication rate (morbidity and mortality 
,6%).60 For patients with TIA or mild stroke who do not have atrial fibrillation or 
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moderate-to-severe carotid stenosis, treatment with a daily dose of 50 to 325 mg of 
aspirin is of demonstrated benefit. 
Stroke Prognosis 
                              Several factors affect the prognosis after stroke. They include the 
age of the person, the size, aetiology of stroke and so on. Both short and long term 
mortality is associated with stroke. Studies have shown that the 30-day mortality 
for ischaemic stroke is approximately 8-20% (Sacco 1997)19 versus 40-45% for 
haemorrhagic strokes (Dennis 2003)63. However, despite this initial significant 
difference, the long-term prognosis has been reported to be similar independent of 
the stroke type, although the mortality rate remains higher for haemorrhagic than 
for ischaemic stroke (Dennis 2003)63The figure shows the survival rate over four 
years from the Oxfordshire7 Community Stroke Project, comparing ischaemic and 
haemorrhagic strokes (Dennis et al. 1993)62 
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PICH, Primary Intracerebral Haemorrhage. Source: (Dennis et al. 1993)62 
 
Stroke Outcome Measures 
                      Stroke outcome is measured for short term as well as long term. 
Outcomes have been described using a number of measurements, but have mainly 
been categorised according to mortality, disability and quality of life.  Outcome 
measures have also been categorised into three different domains – survival rate, 
disability / functional status and quality of life / psychosocial consequence (Flick 
1999). There is no consensus concerning the measures that best reflect stroke 
related disability. Survival rate has been determined according to stroke severity 
and stroke subtypes. Most common impairment measures are NIH stroke scale and 
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Modified Mathew scale. Activity measures include Barthel Index and Rankin 
Handicap Scale. There are several other methods to assess stroke outcome. 
Patients’ emotional, cognitive and living arrangements have also been used as 
indication of the psychosocial consequences. The most common Outcome measure 
in rehabilitation is Functional Independence Measure which incorporates motor, 
social and cognitive performance.  
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General data 
Total number of patients:                    100 
Number of males:                                 64 
Number of females:                              36 
Number of Infarcts:                              88 
Number of hemorrhages:                      12 
Number of males with infarct:              48 
Number of females with infarct:          40 
Number of males with hemorrhage:      8 
Number of females with hemorrhage:   4 
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Clinical features                
General:                                              Infarct                        Hemorrhage 
                                               Total    Male    Female             Male      Female 
Loss of consciousness:                          58           32              15                          7                   4 
           GCS        11-15                           25          14               11                          0                  0                                
                            5-10                            34          17              15                           2                  0 
                               <5                            41          18              13                           6                  4                       
Seizures:                                                  7            1                0                           4                  2 
Urinary incontinence:                            36          15              11                           7                  3 
Vomiting:                                              16            3                5                           6                  2 
Headache:                                              44          15              19                          8                  2 
Hemiplegia\ Hemiparesis:                     72          40              21                          7                  4 
Facio brachial Monoplegia:                  16           10               6                          0                  0             
Monoplegia:                                           5             3                2                          0                  0 
Crossed hemiplegia:                              3              1                2                          0                  0 
Hemianesthesia:                                  18             11               7                          0                  0 
Hemianopia:                                        11              7               4                           0                  0 
Pure cerebellar ataxia:                          2              1                1                           0                  0 
Ataxic Hemiparesis:                             4              3                1                           0                  0  
Aphasia:                                              29            16              11                         1                   1 
Cranial nerves excluding Cr7:             4               3                1                         1                   0 
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Anatomical sites of stroke with sex distribution          
                                                     Male                    Female 
TACS: Total                                   7                          4 
              Infarct:                             5                          3  
             Hemorrhage:                     2                          1 
PACS:  Total                                24                        19 
            Infarct:                             20                        17 
            Hemorrhage:                      4                          2 
LACS:  Total:                              17                         14 
             Infarct:                           16                         14 
             Hemorrhage:                    1                          0 
POCS: Total:                                8                           7 
             Infarct:                            7                           6 
             Hemorrhage:                   1                           1 
Total                                           56                         44 
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Aetiology 
 Infarct:                                                            Total 88                Male   48           Female  40 
             Cardioembolism:                                        9                            3                          6 
             Large Artery Atherosclerosis:                  17                          10                          7 
            Lacunar stroke (small vessel disease):      51                          29                         22 
           Other:                                                          3                            1                            2 
           Undetermined:                                            8                            5                            3 
Hemorrhage: 
             Primary Intracerebral hemorrhage with or without SAH: 
                                                                      Total:           10 
                                                                      Male:            7 
                                                                      Female:         3 
             Primary SAH:  
                                                                     Total:             2 
                                                                     Male:             2 
                                                                    Female:          0 
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Intracranial Hemorrhage sites: 
                        Subcortical                 4 
                       Thalamic                      2 
                       Capsuloganglionic       2 
                       Cerebellar                     1 
                       Brainstem                     1 
 
 
 
 
 
Risk factors 
Non-modifiable                                                            
Age and Gender: 
Total Infarct Hemorrhage Age 
male female Male female male female 
15-24 0 1 0 1 0 0 
25-34 0 1 0 1 0 0 
35-44 4 4 4 3 0 1 
45-54 22 13 20 12 2 1 
55-64 27 11 26 11 1 0 
65-74 7 5 4 3 3 2 
75-84 4 1 2 1 2 0 
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Modifiable                                                                        Infarct                 Hemorrhage 
                                          Total         Male    Female       Male   Female      Male        Female 
Hypertension:                       52              28        24             22          20              6                4 
Diabetes mellitus:                 34              20       14              19          14             1                0 
Dyslipidemia:                       14                8         6               8            5              0                1 
Cigarette smoking:               36              34         2              29           2              5                0 
Ischemic heart disease:        18              13         5              12           4               1               1 
Carotid bruit/Stenosis:          3                2          1     2            1               0               0 
Atrial fibrillation:                  9                3          6               3            6              0               0   
TIA or previous stroke:         8               5           3               5            3              0               0 
Peripheral vascular disease:  2               2           0               2            0              0               0    
Obesity:                                 7               5           2               5            2              0               0 
Heavy Alcohol drinking:     12             11          1               6            0               5               1 
Illicit drug use:                      2               2          0               2             0              0                0 
Physical inactivity:               9               6           3               6             3              0                0 
LVH:                                  18             12           6               6             3              6                3 
Vascular malformations:      2              2           0                0             0              2                0 
 
 
 
 
Prognosis 
 
 Improved Deteriorated Dead 
total 69 25 6 
males 49 11 4 
females 20 14 2 
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RESULTS 
 
                     A total of 100 patients were enrolled in the study after leaving out 
those who didn’t satisfy the inclusion criteria. Out of the 100 stroke patients 64 
were males and 36 were females.  
                    Out of this population 88 patients had ischemic stroke. It included 48 
males and 40 females. Hemorrhagic stroke was seen in 12 patients. It included 8 
males and 4 females. 
                 Males considerably outnumber females with stroke in this study, both in 
ischemic and hemorrhagic strokes. 88% of the people had ischemic stroke when 
compared to 12% of hemorrhagic strokes. 
                 Among the clinical features studied, it was seen that most patients 
presented with hemiparesis/hemiplegia. It amounted to 72 % of the cases. Males 
accounted for 47 cases and females 25. That amounts to 65.3 % of male cases and 
34.7% of females.  Loss of consciousness was the next most common feature seen 
in 58%. These findings were the most noted clinical features in both sexes. Next in 
the order of frequency came headache (44%) and then urinary incontinence (36%). 
Next only to them came specific findings like aphasia (29%) and Hemianesthesia 
(18%).  
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                 53.4 % of infarct patients had loss of consciousness while 91.7% of 
patients sustaining hemorrhagic stroke had loss of consciousness. Less than 2 % of 
infarct cases presented with seizures while 50% of hemorrhage patients had 
seizures. 29.55% of patients with ischemic strokes had urinary incontinence while 
83.33% of patients with hemorrhagic strokes suffered urinary incontinence. When 
66.67% of hemorrhagic stroke patients had vomiting, only 9% of ischemic stroke 
patients had vomiting. 69% of ischemic stroke patients had hemiparesis/ 
hemiplegias, while 92% of the hemorrhagic stroke patients sustained unilateral 
weakness. 
                Other features like Hemianesthesia, crossed hemiplegias, aphasias, 
cerebellar features, and ataxic hemiparesis all were common in ischemic infarcts.  
               Majority of the patients presented with a grave GCS score <5 at 
admission (41%). 34% of patients had GCS between 5 and 10 and 25% had a GCS 
between 11 and 15.  83% of the hemorrhagic strokes had a GCS less than 5. All 
females who had hemorrhagic stroke had GCS less than 5 but only 75% of males 
with hemorrhage had GCS less than 5. Favorable GCS scores (11-15) were 
observed only in ischemic strokes. 
               On analyzing the anatomic location of cerebral lesions it is seen that the 
majority of cases are Partial Anterior Circulatory Stroke amounting to 43% of the 
total. Ischemic stroke in the Partial Anterior Circulatory stroke category 
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predominates with a total of 37%. Ischemic strokes prevail high in all the 
circulatory areas and males have an increased prevalence in all areas. Second in the 
order are Lacunar ischemic strokes with 30% of the total. Posterior ischemic 
strokes come third with 13% of total. Among hemorrhagic strokes Partial anterior 
hemorrhagic strokes top the list with 6% of the total. Total anterior circulatory 
strokes were the ones least observed in this study. Another thing which is noted is 
that only 1% of the patients had lacunar hemorrhage, while lacunar infarcts were 
observed in 30 % of the patients.  
              Regarding the etiology of ischemic stroke the maximum numbers of cases 
were due to small vessel disease rather than large vessel arthrosclerosis. These 
small vessel diseases were identified by CT evidence of lacunar infarcts and by 
ruling out atherosclerosis in larger vessels. They constitute 51% of the total. Large 
artery atherosclerosis producing widespread brain damage and generalized 
atherosclerotic evidence like carotid bruits were found in 17% of total strokes. A 
cardiac source of embolus could be found in 9 patients of which 7 had Rheumatic 
heart disease with atrial fibrillation and 2 had ischemic dilated cardiomyopathy. 
The category “others” include 3 cases of ischemic stroke caused by cortical venous 
infarcts. There were 2 females and 1 male. Both female patients were postpartum 
cases but the male had APLA positive status. In spite of extensive evaluation 8 
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cases remained elusive of a diagnosis and are categorised and undetermined which 
included 5 males and 3 females. 
               Males predominate in lacunar and atherosclerotic disease, while this 
study shows that in this population females have an increased incidence of 
cardioembolic stroke and cortical venous thrombosis. One fold increased incidence 
of Cardioembolism noted in this study may be due to the increased prevalence of 
Rheumatic mitral valve disease in Indian females.  
             Radiologic correlation shows that among hemorrhage cases in this study 
out of the total 12 cases, 10 had primary intraparenchymal bleed. None of them 
were found to have berry aneurysms. The site of maximum predilection was 
Subcortical area (33%) followed by thalamic and Capsuloganglionic bleeds (16% 
each). There were cerebellar and brainstem bleeds too. Primary Sub arachnoid 
bleed was seen in 2 cases; both were males with berry aneurysms. 
 
             Analysis of risk factors show that age plays a very important role in stroke. 
In this study maximum number of cases occurred in the age group of 55-64 years 
which contributed 38% of the cases. That is followed by the 45- 54 year old group 
with 35% of cases. When ischemic strokes alone are considered the above said 
distribution is still followed. But when hemorrhage is considered maximum 
incidence is found in the 65-74 year group with 5 % of the total strokes being 
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them. On observing the gender wise distribution, ischemic stroke is seen to occur 
maximally by 55-64 years for males and earlier by 45-54 years for females. 
Hemorrhagic stroke in males and females were maximal during 65-74 years. Only 
10 cases occurred less than 45 years which included 4 males and 6 females. 
             On analyzing the risk factors, it is clearly seen that Hypertension stands 
out as the number one risk factor for both ischemic and hemorrhagic strokes. 52% 
of the stroke patients had hypertension. Among them 80.7% were ischemic strokes 
and 19.3 % were hemorrhagic strokes. Hence it will be seen hypertension 
commonly results in ischemic stroke. 83% of the people with hemorrhagic strokes 
had hypertension where as only 47.7% of ischemic stroke patients had 
hypertension. 
         Next to hypertension, the risk factor maximally found was cigarette\beedi 
smoking. Even though the sheer total amounted to 36% of the total stroke 
sufferers, it will be seen that 94% of them were males. Since only 2 female 
smokers were there in the study, this risk factor predominantly affects males. In 
fact cigarette smoking was found in 53% of the males who had stroke, where as 
hypertension was seen in only 43.7% of males had hypertension. Hence even 
though the total number of stroke patients with hypertension is more than any other 
risk factor, in this study it is seen that cigarette smoking stays number one among 
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males. Among females hypertension is the top most risk factor with 66.67% of 
them having hypertension. 
              Diabetes mellitus came as the third highest risk factor with 34% of stroke 
patients having it. It came up to the third maximum risk factor for males and the 
second maximum risk factor for females. 31% of males with stroke had diabetes, 
while 38% of females had diabetes mellitus.  
            Ischemic heart disease was found in 18% of people along with LVH in 18% 
of stroke patients. 10% of ischemic stroke patients had LVH while 75% of 
hemorrhagic stroke cases had LVH, corresponding with the increased association 
with hypertension. 
           14% of stroke sufferers had dyslipidemia affecting 12.5% of males and 16% 
of females. Since majority of the female patients were post menopausal, this 
increased association with dyslipidemia and stroke may imply the influence of 
postmenopausal hormonal status on the lipid and cardiovascular status. 92.86% of 
them had ischemic strokes compared to 7.14% of hemorrhagic strokes. 
            Alcoholism was found in 12% of stroke patients. The only female alcoholic 
enrolled into the study sustained hemorrhagic stroke. Next to hypertension and 
LVH, alcoholism contributes maximum as a risk factor to hemorrhagic strokes 
(50%). 
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            Obesity, peripheral vascular disease, TIA, physical inactivity, atrial 
fibrillation, carotid bruits, and illicit drug use all were associated with ischemic 
strokes. 2 patients, both of them males, who had vascular malformations sustained 
hemorrhagic strokes. 
            Of the total of 100 cases 6 patients had died by the end of 1st week. Even 
though 4 males had died when compared to 2 females, it amounted to 6% of total 
males and 5% of females. Of these cases 3 were hemorrhagic strokes and an equal 
number of ischemic strokes, which amounted to 25 % of hemorrhagic strokes and 
3.4% of ischemic strokes. Thus it can be clearly seen that hemorrhagic strokes had 
very high mortalities and males and females were equally affected. 25% of the 
cases deteriorated which included 7 hemorrhagic strokes (58%) and 18 ischemic 
strokes (20%).  Hence morbidity is also more in hemorrhagic strokes. 17% of 
males had deteriorated and 38.9% of females had deteriorated.  69% of total stroke 
sufferers improved at the end of one week. 76% of male stroke sufferers improved 
while only 55 % of females had improvement. Thus in this study it is noted that 
females had more morbidity and poor recovery even though mortality rates were 
comparable between both sexes.  
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DISCUSSION 
 
        In this study stroke patients have been observed for a period of 1 week. The 
clinical features, risk factors, type and site of stroke are all noted along with the 
week end prognosis. The findings observed are herewith described relating to the 
conclusions of some other similar studies. Since the differences in profile so 
brought to light will allow us to make conclusions regarding the community in 
which this study was done. 
             In this study a 28% greater incidence of stroke in males (64%) when 
compared to females (36%) was noted. 30% higher incidence of stroke in men has 
been observed in many studies. (Bamford et al. 1988)7. Strokes due to pregnancy, 
puerperium, oral contraceptive use, migraine or saccular aneurysms are more 
common in women, while atherosclerosis is more common in men (Adams et al. 
2002).25 
              Ischemic stroke (88%) is much more common than hemorrhagic stroke 
(12%). This goes well in accordance with American Heart Association’s estimate 
that 87% of all strokes are ischemic, the remainder being intracerebral and 
subarachnoid hemorrhage strokes 
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          Most common clinical feature was hemiplegia/hemiparesis (72%), followed by 
loss of consciousness (58%), headache (44%) and urinary incontinence (36%). 
This is corroborated by other studies done in India like the one by Man Mohan 
Mehndiratta et al. which found that 80.3% had hemiplegia. Loss of consciousness, 
seizures, urinary incontinence and vomiting were all common in hemorrhagic 
stroke when compared to ischemic strokes. Females with hemorrhagic stroke 
present with lesser GCS than men with hemorrhagic strokes 
        Partial anterior circulatory strokes were most common (43%). Most common 
Ischemic strokes were partial anterior circulatory strokes (37%), but so do 
hemorrhagic strokes (6%) in this territory itself. Similar results were obtained by 
Qiu F64, et al. where PACS was seen in 51% and LACS in 34%. In our study 
LACS was found in 30%. Bamford et al.7 showed similar results with 25 % of 
cases with LACS. 
         Most common etiology was small vessel disease amounting to 51%, followed 
by large artery atherosclerosis (17%). In both cases males predominate. According 
to study conducted in china64 28.6% of patients were found to have small vessel 
disease. 
Our population is seen to have more of atherosclerosis and small vessel disease 
when compared to other studies. 
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        Females had one fold increased incidence of cardio-embolism, which may be 
due to the increased prevalence of Rheumatic heart disease among females.  
         The age group with maximum incidence is 55-64 years amounting to 38% of 
total.  
   The age group 45-64 years together constituted 73% of stroke in this study. 
Where as in western communities stroke incidence peaks much later. This may be 
due to our risk factor profile and other genetic constitutions. The smaller life 
expectancy if Indians may be another reason for earlier peaking of stroke in 
Indians. In Framingham heart study 64% of cases occurred between 65-84 yrs age 
group and only 30.15% cases occurred in the 45-64 yrs group. Hemorrhagic 
strokes occurred much later at 65-74 yrs maximally. 
             Hypertension, the most common risk factor for both ischemic and 
hemorrhagic strokes and was found in 52% of patients. Hypertension commonly 
resulted in more ischemic strokes (80.7%) when compared to hemorrhages. Other 
studies prove that hypertensives have a fourfold greater risk of stroke at systolic 
blood pressure values ≥160.19 Data from other studies also show that treatment of 
hypertension reduces stroke risk by approximately 38%. 21    
        Cigarette smoking was the second greatest risk factor for stroke (36%), but 
among males it stands as the most common risk factor pushing hypertension to the 
second place. Honolulu heart programme affirmatively links cigarette smoking 
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with both ischemic and hemorrhagic strokes. In this study cigarette smoking had 
more correlation with hemorrhagic strokes. 
          Diabetes mellitus came as the next greatest risk factor with 34% of stroke 
patients suffering from it. According to some studies the frequency of diabetes 
mellitus was found to be higher in Indian population 18%-42.5% (sandercock et 
al.)17  than in the western population 10% to 26%. 37 This increased prevalence of 
diabetes was reflected in this study too. 
            Ischemic heart disease and LVH was found in 18% of patients each and 
LVH was more associated with hemorrhagic stroke. This may be due to the fact 
that in this study that 83% of hemorrhagic stroke patients had hypertension. 
           Dyslipidemia affected 14% of patients and affected more females than 
males. It may be due to the postmenopausal hormonal changes resulting in 
dyslipidemia. Dyslipidemia resulted in ischemic strokes predominantly. Some 
western data correlate with this fact showing that increased level of total 
cholesterol, especially LDL, is associated with a higher incidence of ischaemic 
stroke.51 
              Alcoholism was found in 12% of stroke patients and was more associated 
with hemorrhagic lesions. Other studies revealing the association between Heavy 
alcohol consumption and an increased incidence of haemorrhagic stroke include 
the one done by Thrift et al. 199946. 
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                Increased mortality and morbidity is seen with hemorrhagic strokes when 
compared with ischemic strokes. Even though mortality rates were comparable 
between both sexes, females had more morbidity and poor recovery in this study. 
Studies have shown that the short term mortality for ischaemic stroke is 
approximately 8-20% (Sacco 1997)19 versus 40-45% for haemorrhagic strokes 
(Dennis 2003)63. 
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CONCLUSIONS 
 
 
 Stroke is more common in males (64%) when compared to females (36%). 
 Ischemic stroke (88%) is much more common than hemorrhagic stroke 
(12%). 
 Most common clinical feature was hemiplegia/hemiparesis (72%), followed 
by loss of consciousness (58%), headache (44%) and urinary incontinence 
(36%). 
 Loss of consciousness, seizures, urinary incontinence and vomiting were all 
common in hemorrhagic stroke when compared to ischemic strokes. 
 Majority of the patients presented with GCS <5. Among them females had a 
preponderance of having had a hemorrhagic stroke when compared to males. 
So females with hemorrhagic stroke present with lesser GCS than men with 
hemorrhagic strokes. Favorable GCS scores above 11 were observed only in 
ischemic strokes. 
 Partial anterior circulatory strokes were most common (43%). 
 Most common Ischemic strokes were partial anterior circulatory strokes 
(37%), but so do hemorrhagic strokes (6%) in this territory itself. 
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 Lacunar strokes were more often infarcts (30%) when compared to 
hemorrhages (1%). They are the most common sites of stroke after partial 
anterior circulatory strokes. 
 Most common etiology was small vessel disease amounting to 51%, 
followed by large artery atherosclerosis (17%). In both cases males 
predominate. 
 Cardio-embolism was found in 9% and Rheumatic heart disease with atrial 
fibrillation was the most common cause. Females had one fold increased 
incidence of cardio-embolism, which may be due to the increased prevalence 
of Rheumatic heart disease among females.  
 Cortical venous thrombosis was more common among females. 
 Primary intra-parenchymal bleed was more common than subarachnoid 
hemorrhages. The site of maximum predilection was subcortical area (33%). 
 The age group with maximum incidence is 55-64 years amounting to 38% of 
total, most of them being ischemic. Where as in western communities stroke 
incidence peaks much later. This may be due to our risk factor profile and 
other genetic constitutions.  
 Hemorrhagic strokes occurred much later at 65-74 yrs maximally. 
 Hypertension, the most common risk factor for both ischemic and 
hemorrhagic strokes and was found in 52% of patients. Hypertension 
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commonly resulted in more ischemic strokes (80.7%) when compared to 
hemorrhages. But considering all those who had hemorrhages brings the 
conclusion that 83% of them were hypertensives when compared to 47.7% 
of ischemic stroke patients having had hypertension.  
 Cigarette smoking was the second greatest risk factor for stroke (36%), but 
among males it stands as the most common risk factor pushing hypertension 
to the second place. But among females hypertension remains the most 
common risk factor. 
 Diabetes mellitus came as the next greatest risk factor with 34% of stroke 
patients suffering from it. 
 Ischemic heart disease and LVH was found in 18% of patients each and 
LVH was more associated with hemorrhagic stroke. This may be due to the 
fact that in this study that 83% of hemorrhagic stroke patients had 
hypertension. 
 Dyslipidemia affected 14% of patients and affected more females than 
males. It may be due to the postmenopausal hormonal changes resulting in 
dyslipidemia. Dyslipidemia resulted in ischemic strokes predominantly. 
 Alcoholism was found in 12% of stroke patients and was more associated 
with hemorrhagic lesions. 
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 Increased mortality and morbidity is seen with hemorrhagic strokes when 
compared with ischemic strokes. Even though mortality rates were 
comparable between both sexes, females had more morbidity and poor 
recovery in this study.  
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Proforma: CLINICO-RADIOLOGICAL PROFILE, RISK 
FACTOR ASSESSMENT, ETIOLOGY AND PROGNOSIS IN 
ACUTE CVA 
Name:                               Age:                    Sex:                     MRD No: 
                                                                                                Serial No: 
COMPLAINTS: 
Clinical H/o:                                    Hemiplegia/Hemiparesis: 
Past H/o Stroke:                              Faciobrachial monoplegia: 
Past H/o TIA:                                  Monoplegia: 
Loss of consciousness:                    Crossed hemiplegia: 
Seizures:                                          Ataxic hemiparesis: 
Vomiting:                                         Pure cerebellar ataxia: 
Headache:                                        Hemianesthesia: 
Urinary incontinence:                      Hemianopia: 
Aphasia:                                          Crania nerves other than facial N: 
                                 RISK FACTORS          Yes                           No 
Systemic HT 
Diabetes Mellitus 
CAD 
Other Heart diseases 
Cigarette smoking 
Dyslipidemia 
Carotid bruit/ stenosis  
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Atrial fibrillation: 
H/o TIA or previous stroke 
Peripheral vascular disease 
Obesity 
Heavy alcohol drinking 
Illicit drug use 
Physical inactivity  
LVH 
Vascular malformations 
 
EXAMINATION FINDINGS: 
Height:                                       Weight:                              BMI: 
PR:           BP:             
CVS:                                    RS:                                 GIT: 
CNS:          GCS: 
                   Deficit:                                                 Power: 
                   Cranial Nerve palsy: 
                   Sensory:                                              Cerebellar: 
INVESTIGATIONS 
Hb:                                  ESR                                         S. Cholesterol: 
FBS:                               PPBS:                                      TG: 
Blood Urea:                    CXR:                   LDL:  
S. Creatinine:                  ECG: 
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CT scan findings:                                                                                Yes            No 
Type:          Infarct 
                   Hemorrhage          Intra parenchymal 
                                                    SAH 
                    CVT  
Location of infarct:     Total Anterior Circulation Stroke 
                                   Partial Anterior Circulation Stroke 
                                   Lacunar Stroke 
                                   Posterior Circulation Stroke 
Location of intraparenchymal hemorrhage:  Subcortical 
                                                                     Thalamic 
                                                                     Capsuloganglionic 
                                                                     Cerebellar 
                                                                     Brainstem                   
Aetiology of infarcts:       Cardioembolism  
                                         Large Artery Atherosclerosis 
                                         Lacunar stroke (small vessel disease):                    
                                         Other:                                                      
                                         Undetermined:      
Progress after 1 week:  
                Improved 
                Deteriorated 
                Expired 
 
 
 
 
 
 
 
  
  
 TACS- Total Anterior Circulatory Stroke, PACS- Partial Anterior Circulatory Stroke,  
LACS- Lacunar Stroke, POCS- Posterior Circulatory Stroke 
I – Infarct and H- Hemorrhage 
 
 
 
 
 
 
 
